203 related articles for article (PubMed ID: 8891007)
1. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
[TBL] [Abstract][Full Text] [Related]
2. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
4. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
Uchio E; Matsumoto T; Tanaka SI; Ohno S
Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis: comparison of immunological markers in patients with acute and remission phase.
De Pità O; Ruffelli M; Cadoni S; Frezzolini A; Biava GF; Simom R; Bottari V; De Sanctis G
J Dermatol Sci; 1996 Nov; 13(2):118-24. PubMed ID: 8953411
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
Srivastava MD; Rossi TM; Lebenthal E
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
[TBL] [Abstract][Full Text] [Related]
7. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
[TBL] [Abstract][Full Text] [Related]
9. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
10. Patterns of cytokines and soluble cellular receptors in the sera of children with acute chagas' disease.
Moretti E; Basso B; Cervetta L; Brigada A; Barbieri G
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1324-7. PubMed ID: 12414768
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
Orditura M; De Vita F; Roscigno A; Auriemma A; Infusino S; Catalano G
Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
[TBL] [Abstract][Full Text] [Related]
12. T-cell evaluation in patients with colon cancer: dinitrochlorobenzene skin testing versus plasma levels of sIL-2r and sCD8.
Bleeker WA; de Ley L; Oeseburg HB; Martens A; Mulder NH; Hermans J; Plukker JT
Ann Surg Oncol; 1998; 5(3):209-12. PubMed ID: 9607619
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis.
Schriefer A; Barral A; Carvalho EM; Barral-Netto M
Clin Exp Immunol; 1995 Dec; 102(3):535-40. PubMed ID: 8536369
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia.
Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Squadrito G
Acta Haematol; 1991; 85(2):57-61. PubMed ID: 1902614
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
[TBL] [Abstract][Full Text] [Related]
17. Serum markers of T-cell activation in relapses of Wegener's granulomatosis.
Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
Adv Exp Med Biol; 1993; 336():389-92. PubMed ID: 8296642
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
19. Serum soluble CD4, CD8 and IL-2R levels in adult acute myeloid leukemia in remission.
Iizuka Y; Aiso M; Ohshima T; Sawada S; Horie T
Med Oncol Tumor Pharmacother; 1992; 9(2):57-64. PubMed ID: 1341717
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serial measurement of the serum levels of soluble interleukin-2 receptor and soluble CD8 in malignant lymphoma.
Motokura T; Kobayashi Y; Fujita A; Nakamura Y; Taniguchi T; Uchimaru K; Asano S
Leuk Lymphoma; 1995 Jan; 16(3-4):355-62. PubMed ID: 7719243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]